Tirzepatide (Mounjaro)-induced acute pancreatitis and ketoacidosis in an adult nondiabetic patient
Tirzepatide (Mounjaro) is a new medication approved for type 2 diabetes and obesity treatment. It works by activating the receptors for both glucose-dependent insulinotropic peptide and glucagon-like peptide-1. Side effects due to tirzepatide are typically gastrointestinal in nature and self-resolvi...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| coleção: | Saudi Journal for Health Sciences |
| Assuntos: | |
| Acesso em linha: | https://journals.lww.com/10.4103/sjhs.sjhs_122_24 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|